Regarding tumor stage, a study conducted by Yuan et al [43] reported that HCC patients with KIAA0101 overexpression were two times more likely to have advanced-stage disease than those with normal expression, as confirmed in Abdelgawad’s study [29]. This evidence concerns the gene PCLAF and hepatocellular carcinoma.